Fig. 1
From: Combination of serum lipids and cancer antigens as a novel marker for colon cancer diagnosis
Serum lipids and cancer antigens in patients and healthy subjects. Blood samples collected from 200 colon cancer patients or 200 healthy controls. (a-b) Serum lipids including TC, TG (a), HDL and LDL (b) were quantified on an Automatic Biochemical Analyzer machine. (c) Serum CEA and CA19–9 were also measured by ELISA. Data were presented as mean ± SD, and analyzed by student t-test. *P < 0.05, **P < 0.01